Literature DB >> 19762243

Design, synthesis and evaluation of monovalent ligands for the asialoglycoprotein receptor (ASGP-R).

Daniela Stokmaier1, Oleg Khorev, Brian Cutting, Rita Born, Daniel Ricklin, Thomas O G Ernst, Fabienne Böni, Kathrin Schwingruber, Martin Gentner, Matthias Wittwer, Morena Spreafico, Angelo Vedani, Said Rabbani, Oliver Schwardt, Beat Ernst.   

Abstract

A series of novel aryl-substituted triazolyl D-galactosamine derivatives was synthesized as ligands for the carbohydrate recognition domain of the major subunit H1 (H1-CRD) of the human asialoglycoprotein receptor (ASGP-R). The compounds were biologically evaluated with a newly developed competitive binding assay, surface plasmon resonance and by a competitive NMR binding experiment. With compound 1b, a new ligand with a twofold improved affinity to the best so far known D-GalNAc was identified. This small, drug-like ligand can be used as targeting device for drug delivery to hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762243     DOI: 10.1016/j.bmc.2009.08.049

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Liver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeutics.

Authors:  Jinjin Zhang; Jered C Garrison; Larisa Y Poluektova; Tatiana K Bronich; Natalia A Osna
Journal:  Biomaterials       Date:  2015-08-08       Impact factor: 12.479

2.  Epitope structure of the carbohydrate recognition domain of asialoglycoprotein receptor to a monoclonal antibody revealed by high-resolution proteolytic excision mass spectrometry.

Authors:  Raluca Stefanescu; Rita Born; Adrian Moise; Beat Ernst; Michael Przybylski
Journal:  J Am Soc Mass Spectrom       Date:  2011-01-20       Impact factor: 3.109

3.  Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor.

Authors:  Carlos A Sanhueza; Michael M Baksh; Benjamin Thuma; Marc D Roy; Sanjay Dutta; Cathy Préville; Boris A Chrunyk; Kevin Beaumont; Robert Dullea; Mark Ammirati; Shenping Liu; David Gebhard; James E Finley; Christopher T Salatto; Amanda King-Ahmad; Ingrid Stock; Karen Atkinson; Benjamin Reidich; Wen Lin; Rajesh Kumar; Meihua Tu; Elnaz Menhaji-Klotz; David A Price; Spiros Liras; M G Finn; Vincent Mascitti
Journal:  J Am Chem Soc       Date:  2017-02-23       Impact factor: 15.419

4.  Synthesis of multi-lactose-appended β-cyclodextrin and its cholesterol-lowering effects in Niemann-Pick type C disease-like HepG2 cells.

Authors:  Keiichi Motoyama; Rena Nishiyama; Yuki Maeda; Taishi Higashi; Yoichi Ishitsuka; Yuki Kondo; Tetsumi Irie; Takumi Era; Hidetoshi Arima
Journal:  Beilstein J Org Chem       Date:  2017-01-03       Impact factor: 2.883

Review 5.  PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease.

Authors:  Tuo Shao; Lee Josephson; Steven H Liang
Journal:  Mol Imaging       Date:  2019 Jan-Dec       Impact factor: 4.488

6.  Preparation and evaluation of LA-PEG-SPION, a targeted MRI contrast agent for liver cancer.

Authors:  Lei Xia; Xiaowei Song; Guanghai Yan; Jishan Quan; Guangyu Jin
Journal:  Open Life Sci       Date:  2022-08-15       Impact factor: 1.311

7.  A Modular Ionophore Platform for Liver-Directed Copper Supplementation in Cells and Animals.

Authors:  Timothy A Su; Diyala S Shihadih; Wendy Cao; Tyler C Detomasi; Marie C Heffern; Shang Jia; Andreas Stahl; Christopher J Chang
Journal:  J Am Chem Soc       Date:  2018-10-15       Impact factor: 16.383

8.  Cholesterol lowering effects of mono-lactose-appended β-cyclodextrin in Niemann-Pick type C disease-like HepG2 cells.

Authors:  Keiichi Motoyama; Yumi Hirai; Rena Nishiyama; Yuki Maeda; Taishi Higashi; Yoichi Ishitsuka; Yuki Kondo; Tetsumi Irie; Takumi Era; Hidetoshi Arima
Journal:  Beilstein J Org Chem       Date:  2015-11-03       Impact factor: 2.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.